An EORTC phase I study of capecitabine (Xeloda) in combination with fixed doses of cyclophosphamide and epirubicin (cex) as primary treatment for large operable or locally advanced/inflammatory breast cancer.

Bonnefoi H., Biganzoli L., Mauriac L., Cufer T., Schaefer P., Atalay G., ...More

European journal of cancer (Oxford, England : 1990), vol.39, pp.1277-83, 2003 (SCI-Expanded, Scopus)

• Publication Type: Article / Article
• Volume: 39
• Publication Date: 2003
• Doi Number: 10.1016/s0959-8049(03)00266-1
• Journal Name: European journal of cancer (Oxford, England : 1990)
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.1277-83
• Acibadem Mehmet Ali Aydinlar University Affiliated: No